Comparative Study of 5-Day and 10-Day Cefditoren Pivoxil Treatments for Recurrent Group A <svg     style="vertical-align:-4.698pt;width:13.15px;" id="M1" height="21.9375" version="1.1" viewBox="0 0 13.15 21.9375" width="13.15"  xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/2000/svg">
	
		
			<g transform="matrix(.022,-0,0,-.022,.062,16.025)"><path id="x1D6FD" d="M558 587q0 -32 -14 -61t-40 -53.5t-48.5 -41t-54.5 -36.5q144 -51 144 -174q0 -55 -43.5 -108t-104.5 -87q-77 -42 -131 -42q-31 0 -54 20t-31 47l11 18q48 -29 108 -29q79 0 119.5 43t40.5 109t-44.5 107.5t-119.5 50.5l22 47q34 1 65 21q96 61 96 157q0 42 -24 67.5
t-62 25.5q-24 0 -43.5 -9t-35 -29.5t-27 -44t-22.5 -63t-19.5 -75.5t-18.5 -91q-57 -294 -68 -380q-26 -190 -35 -200q-26 -31 -97 -37l-4 26q19 9 48 170l77 413q23 121 52.5 187.5t83.5 114.5q70 62 148 62q51 0 88.5 -34t37.5 -91z" /></g>

		
	
</svg>-Hemolytic <i  >Streptococcus pharyngitis</i> in Children

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr class="thead"><td align="left">Results</td><td align="center">Total</td><td align="center">5-day treatment group</td><td align="center">10-day treatment group</td><td align="center"><i>P</i>  value</td></tr><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr><td align="left">Recurrence (clinical treatment failure)</td><td align="center">8/226</td><td align="center">7/77</td><td align="center">1/149</td><td align="center">.003</td></tr><tr><td align="left">Bacteriologic treatment failure
 (noneradication)</td><td align="center">24/226</td><td align="center">7/77</td><td align="center">17/149</td><td align="center">.655</td></tr><tr><td align="left">Treatment failure</td><td align="center">32/226</td><td align="center">14/77</td><td align="center">18/149</td><td align="center">.231</td></tr><tr class="table-tr"><td colspan="5"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

International Journal of Pediatrics

tab2

Table 2

Table 2: Comparative Study of 5-Day and 10-Day Cefditoren Pivoxil Treatments for Recurrent Group A <svg     style="vertical-align:-4.698pt;width:13.15px;" id="M1" height="21.9375" version="1.1" viewBox="0 0 13.15 21.9375" width="13.15"  xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/2000/svg">
	
		
			<g transform="matrix(.022,-0,0,-.022,.062,16.025)"><path id="x1D6FD" d="M558 587q0 -32 -14 -61t-40 -53.5t-48.5 -41t-54.5 -36.5q144 -51 144 -174q0 -55 -43.5 -108t-104.5 -87q-77 -42 -131 -42q-31 0 -54 20t-31 47l11 18q48 -29 108 -29q79 0 119.5 43t40.5 109t-44.5 107.5t-119.5 50.5l22 47q34 1 65 21q96 61 96 157q0 42 -24 67.5
t-62 25.5q-24 0 -43.5 -9t-35 -29.5t-27 -44t-22.5 -63t-19.5 -75.5t-18.5 -91q-57 -294 -68 -380q-26 -190 -35 -200q-26 -31 -97 -37l-4 26q19 9 48 170l77 413q23 121 52.5 187.5t83.5 114.5q70 62 148 62q51 0 88.5 -34t37.5 -91z" /></g>

		
	
</svg>-Hemolytic <i  >Streptococcus pharyngitis</i> in Children 

Table 2 | Comparative Study of 5-Day and 10-Day Cefditoren Pivoxil Treatments for Recurrent Group A 
	
		
			

		
	
-Hemolytic Streptococcus pharyngitis in Children 

International Journal of Pediatrics

Comparative Study of 5-Day and 10-Day Cefditoren Pivoxil Treatments for Recurrent Group A -Hemolytic Streptococcus pharyngitis in Children

Table 2